Real-world evaluation of treatment patterns and resource utilization in Japanese patients with multiple myeloma using the MDV database
The challenge
Putnam PHMR’s client needed a detailed description of multiple myeloma treatment patterns and resource utilization in Japanese patients.
Our approach
Using the data source of The Medical Data Vision (MDV) database (2008 – 2015), our RWE and
Biostatistics team worked to:
- Describe the MM drug strategies dispensed in 1st line, 2nd line, and 3rd line.
- Estimate the probabilities and the time to treatment-related events (switch, add-on, reduction
and discontinuation). - Estimate the healthcare resource uses for the observed treatment pathways.
- Estimate the probabilities and the time to of MM-related complication events (e.g.
hypercalcemia, renal insufficiency, anemia, skeletal lesions). - Estimate the probabilities and the time to treatment-related adverse events.
The results
With our RWE and Biostatistics team’s findings, we came to the solution of generating a retrospective longitudinal observational cohort study exploring the treatment pattern of patients and related outcomes in patients with multiple myeloma.
Jump to a slide with the slide dots.
Jo Ann Saitta
Accelerated Real-World Insight: How AI and Claims Data Rapidly Turn Gaps into Health Equity Action
AI and claims data bridge health equity gaps in cardiovascular care, uncovering disparities and providing actionable solutions to improve access.
Read morePatient Finding Through Data Tokenization
Refined HCP targeting in rare disease using integrated data, boosting hit rates from 10% to 50% and delivering 3x ROI in 6 months.
Read moreDigital share of voice and sentiment analysis at key congress
Used GenAI to benchmark digital voice in oncology, boosting engagement & leadership via LinkedIn, DEI & clinical messaging.
Read more